# Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation

> **NCT02711995** · NA · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 8 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** RenuGel
- **DRUG:** Botulinum Toxin

## Key facts

- **NCT ID:** NCT02711995
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-15
- **Primary completion:** 2016-09-29
- **Final completion:** 2016-09-29
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02711995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02711995, "Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02711995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*